-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Merck announced today that the European Medicines Management Agency Committee medicines for human use (CHMP) has recommended approval VAXNEUVANCE ™ (Pneumococcal 15 valent conjugate vaccine) for active immunization to prevent 18-year-old and Streptococcus pneumoniae caused more than individual invasive Disease and pneumonia
.
The CHMP proposal will now be reviewed by the European Commission for marketing authorization in the EU, and a final decision is expected to be made by the end of the year
.
CHMP’s opinion is based on data from seven randomized, double-blind clinical studies that evaluated 7,438 individuals from various adult populations and clinical situations
.
In July 2021, VAXNEUVANCE was approved by the U.
FDA
Pneumococcal disease (an infection caused by Streptococcus pneumoniae ) is circulating globally
.
Highly invasive strains or serotypes may put more people at risk of invasive pneumococcal diseases such as bacteremia (blood infection)
Infect
VAXNEUVANCE is Merck's 15-valent pneumococcal conjugate vaccine, which is composed of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F, 32F and 32F.
Purified capsular polysaccharide composition, coupled with CRM197 carrier protein
.
Purified capsular polysaccharide composition, coupled with CRM197 carrier protein
.
VAXNEUVANCE is Merck's 15-valent pneumococcal conjugate vaccine, which is composed of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F, 32F and 32F.
Original source:
Original source:https:// href="https://" target="_blank" rel="noopener">https:// https:// Leave a message here